Literature DB >> 29274003

Should we consider integrated approach for endometriosis-associated infertility as gold standard management? Rationale and results from a large cohort analysis.

Vesna Šalamun1, Ivan Verdenik1, Antonio Simone Laganà2, Eda Vrtačnik-Bokal1.   

Abstract

PURPOSE: To evaluate reproductive and maternal-fetal outcomes after integrated approach for endometriosis-associated infertility (EAI).
METHODS: We retrospectively analyzed reproductive and maternal-fetal outcomes of 277 women affected by EAI, subdividing patients in two groups: in the first one (surgery group), we included all women who underwent laparoscopic surgery for EAI; in the second one (integrated group), we included women who failed to conceive spontaneously after surgery within 6-12 months and underwent in vitro fertilization and embryo transfer (IVF). We evaluated delivery rate (DR), maternal and neonatal outcomes of the first pregnancies, and, finally, the type (spontaneous or IVF) of subsequent pregnancies.
RESULTS: We did not find significant difference regarding DR between surgery and integrated groups. We found significantly lower birth weight (p < 0.001) and gestational age at delivery (p < 0.001) in integrated group respect to surgery group; conversely, we found higher rate of preterm birth (p < 0.001), small for gestational age (p = 0.003), and admission to the neonatal intensive care unit (p < 0.001) respect to surgery group. Finally, 92 women became pregnant for the second time: 8% were spontaneous and 20% were IVF pregnancies.
CONCLUSIONS: We suggest the integrated approach as gold standard treatment for carefully selected patients (young, good ovarian reserve, partner with normal semen parameters) affected by EAI. As consequence, IVF should be reserved as the secondary treatment for women who fail to conceive spontaneously after surgery within 6-12 months, since it is able to increase DR significantly.

Entities:  

Keywords:  Delivery rate; Endometriosis; In vitro fertilization; Infertility treatment; Laparoscopy; Obstetric outcomes

Mesh:

Year:  2017        PMID: 29274003     DOI: 10.1007/s00404-017-4633-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

1.  In vitro Maturation of Oocytes with Consecutive Clinical Pregnancy after Accidental Premature Ovulation Induction-A Rescue Strategy in Art.

Authors:  S Findeklee; J Hachenberg; K Kienast
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

2.  Pre-IVF treatment with a GnRH antagonist in women with endometriosis (PREGNANT): study protocol for a prospective, double-blind, placebo-controlled trial.

Authors:  Hugh Taylor; Howard J Li; Sandra Carson; Valerie Flores; Lubna Pal; Jared Robbins; Nanette F Santoro; James H Segars; David Seifer; Hao Huang; Steven Young; Heping Zhang
Journal:  BMJ Open       Date:  2022-06-17       Impact factor: 3.006

3.  Protein C global assay evaluation in naturally conceived vs. assisted reproduction-achieved twin pregnancies: a prospective longitudinal study.

Authors:  Johnny S Younis; Mariana Issawy; Ido Izhaki; Izhar Ben-Shlomo; Sofia Soltsman; Yuri Perlitz; Moshe Ben-Ami; Benjamin Brenner; Galit Sarig
Journal:  Arch Gynecol Obstet       Date:  2021-02-09       Impact factor: 2.344

4.  The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment.

Authors:  Xi-Qian Zhang; Li-Jia Zhang; Xiu-Lan Zhu; Hong Xu; Yan-Qun Luo; Li Yao; Qian-Wen Huang; Ying-Qi Nong; Wen-Juan Liu; Feng-Hua Liu
Journal:  Drug Des Devel Ther       Date:  2021-08-16       Impact factor: 4.162

5.  Evaluation of Uterine Artery Doppler and Estrogen Milieu in Oocyte Donation Pregnancies-A Pilot Study.

Authors:  Luca Mandia; Paolo Cavoretto; Piergiorgio Duca; Massimo Candiani; Irene Cetin; Valeria Savasi
Journal:  Diagnostics (Basel)       Date:  2020-04-26

6.  Inflammatory Markers in Peripheral Blood Cells Cannot Predict Intrauterine Insemination Outcome: A Retrospective Cohort Study.

Authors:  Meryem Kuru Pekcan; A Seval Ozgu-Erdinc; Nafiye Yilmaz; Aytekin Tokmak; Yaprak Engin-Ustun
Journal:  J Hum Reprod Sci       Date:  2021-03-30

Review 7.  Management Challenges of Deep Infiltrating Endometriosis.

Authors:  Maurizio Nicola D'Alterio; Gianmarco D'Ancona; Mohamed Raslan; Raffaele Tinelli; Angelos Daniilidis; Stefano Angioni
Journal:  Int J Fertil Steril       Date:  2021-03-11

8.  Pre-Implantation Gender Selection: Family Balancing in Jordan.

Authors:  Amer Mahmoud Sindiani; Faheem Zayed; Eman Hussein Alshdaifat; Hasan M Rawashdeh; Wesam Al-Woshah; Nada Zayed
Journal:  Risk Manag Healthc Policy       Date:  2021-07-02

Review 9.  Ion Channels in The Pathogenesis of Endometriosis: A Cutting-Edge Point of View.

Authors:  Gaetano Riemma; Antonio Simone Laganà; Antonio Schiattarella; Simone Garzon; Luigi Cobellis; Raffaele Autiero; Federico Licciardi; Luigi Della Corte; Marco La Verde; Pasquale De Franciscis
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

10.  There is a cycle to cycle variation in ovarian response and pre-hCG serum progesterone level: an analysis of 244 consecutive IVF cycles.

Authors:  Sule Yildiz; Kayhan Yakin; Baris Ata; Ozgur Oktem
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.